GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ishita Drugs And Industries Ltd (BOM:524400) » Definitions » EV-to-EBIT

Ishita Drugs And Industries (BOM:524400) EV-to-EBIT : 15.66 (As of May. 04, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ishita Drugs And Industries EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ishita Drugs And Industries's Enterprise Value is ₹151.9 Mil. Ishita Drugs And Industries's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹9.7 Mil. Therefore, Ishita Drugs And Industries's EV-to-EBIT for today is 15.66.

The historical rank and industry rank for Ishita Drugs And Industries's EV-to-EBIT or its related term are showing as below:

BOM:524400' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.66   Med: 10.58   Max: 37.28
Current: 15.66

During the past 13 years, the highest EV-to-EBIT of Ishita Drugs And Industries was 37.28. The lowest was -3.66. And the median was 10.58.

BOM:524400's EV-to-EBIT is ranked better than
57.72% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs BOM:524400: 15.66

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ishita Drugs And Industries's Enterprise Value for the quarter that ended in Dec. 2023 was ₹215.1 Mil. Ishita Drugs And Industries's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹9.7 Mil. Ishita Drugs And Industries's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.51%.


Ishita Drugs And Industries EV-to-EBIT Historical Data

The historical data trend for Ishita Drugs And Industries's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ishita Drugs And Industries EV-to-EBIT Chart

Ishita Drugs And Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.59 -3.44 3.35 3.71 11.26

Ishita Drugs And Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.55 11.26 29.27 15.77 22.18

Competitive Comparison of Ishita Drugs And Industries's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ishita Drugs And Industries's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's EV-to-EBIT falls into.



Ishita Drugs And Industries EV-to-EBIT Calculation

Ishita Drugs And Industries's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=151.870/9.697
=15.66

Ishita Drugs And Industries's current Enterprise Value is ₹151.9 Mil.
Ishita Drugs And Industries's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ishita Drugs And Industries  (BOM:524400) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ishita Drugs And Industries's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=9.697/215.122182
=4.51 %

Ishita Drugs And Industries's Enterprise Value for the quarter that ended in Dec. 2023 was ₹215.1 Mil.
Ishita Drugs And Industries's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ishita Drugs And Industries EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ishita Drugs And Industries's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ishita Drugs And Industries (BOM:524400) Business Description

Traded in Other Exchanges
N/A
Address
C.G.Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. It manufactures high quality products and is known for its ethical dealings in business. The company supplies its products to various pharmaceutical companies and also being export to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar and one for finished pharmaceutical formulations at Mehsana.

Ishita Drugs And Industries (BOM:524400) Headlines

No Headlines